You can change your cookie settings at any time. This publication is licensed under the terms of the Open Government Licence v3. To view this licence, visit nationalarchives.
Biedler Prize for Cancer Journalism. Home Newsroom News Release Detail. Interval cancers are often more aggressive and lethal than mammography-detected cancers.
To assess the impact of the participation in screening programme according to the mode of detection on the early diagnosis, treatment, and specific survival outcomes in women with breast cancer. Women diagnosed with invasive breast cancer in Poitou-Charentes region France between and were classified into three groups, using data linkage of cancer registry, vital statistics and French organized screening programme: the screening programme SPinterval cancer ICand non-screening programme detected cancer NSP groups. Specific survival rates were analysed using the Kaplan—Meier method and Cox proportional hazard models.
Mundell, Healthday Reporter. HealthDay —About 15 percent of breast cancers are diagnosed in the interval between regularly scheduled mammograms, where the last mammogram showed no signs of a cancer. Now, new research suggests that these "interval cancers" may have a worse prognosisespecially for younger women.
We respect your privacy. Interval breast cancers include situations where a tumor was present when the mammography was performed but the cancer was missed, as well as tumors that arise during the interval between mammograms. These fast-growing tumors tend to be more aggressive and associated with a poorer prognosis.
Thank you for visiting nature. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer.
HealthDay News — The likelihood of having breast cancer with a poor prognosis is increased for cancer diagnosed after a screening mammography with negative results, according to a research letter published online May 3 in JAMA Oncology. Anne Marie McCarthy, Ph. The researchers found that the likelihood of a poor prognosis was increased for cases of cancer diagnosed after screening mammography with negative results versus those diagnosed after mammography with positive results
E-mail address: ian. Use the link below to share a full-text version of this article with your friends and colleagues. Learn more. Therefore, we assessed both germline and somatic genomic aberrations in a prospective cohort.
Breast cancers that develop between routine screening exams are likely to grow more rapidly and be associated with poorer prognosis than cancers that are present at the time of screening mammography but go undetected, researchers have reported in JAMA Oncology. In these cases, the authors said, a poor prognosis is indicated by red flags like distant metastases, cancer-positive regional lymph nodes, larger HER2-negative invasive cancers and receptor-positive cancers. Women recruited for the study were above 40 years old, had no prior diagnosis of breast cancer and had received screening mammography between and
In a study reported in JAMA OncologyMcCarthy et al identified the risk of interval breast cancer after negative screening mammography, including risk of poor-prognosis breast cancer. Cancer diagnoses within 1 year after screening were obtained from state registries. Amongwomen included in the analysis, screening mammography was negative in ,